Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients

por Martinowitz, U, Lissitchkov, T, Lubetsky, A, Jotov, G, Barazani-Brutman, T, Voigt, C, Jacobs, I, Wuerfel, T, Santagostino, E
Publicado 2015